Nalaganje...

The effect of erythropoietin on the severity of retinopathy of prematurity

AIMS: Exogenous human erythropoietin (EPO) artificially synthesised through recombinant DNA technology (rHuEPO) is currently used as a substitute for blood transfusion in preterm and low birth weight neonates. The objective of this study is to determine whether the use of rHuEPO is associated with a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Kandasamy, Y, Kumar, P, Hartley, L
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2014
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4094820/
https://ncbi.nlm.nih.gov/pubmed/24763242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2014.95
Oznake: Označite
Brez oznak, prvi označite!